165 related articles for article (PubMed ID: 37208644)
1. Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Yang X; Wu Y; Xu S; Li H; Peng C; Cui X; Dhoomun DK; Wang G; Xu T; Dong M; Li X; Du Y
BMC Endocr Disord; 2023 May; 23(1):113. PubMed ID: 37208644
[TBL] [Abstract][Full Text] [Related]
2. The human inward rectifier K(+) channel subunit kir5.1 (KCNJ16) maps to chromosome 17q25 and is expressed in kidney and pancreas.
Liu Y; McKenna E; Figueroa DJ; Blevins R; Austin CP; Bennett PB; Swanson R
Cytogenet Cell Genet; 2000; 90(1-2):60-3. PubMed ID: 11060447
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Kir5.1 Impairs Renal Ability to Excrete Potassium during Increased Dietary Potassium Intake.
Wu P; Gao ZX; Zhang DD; Su XT; Wang WH; Lin DH
J Am Soc Nephrol; 2019 Aug; 30(8):1425-1438. PubMed ID: 31239388
[TBL] [Abstract][Full Text] [Related]
4.
Poli G; Hasan S; Belia S; Cenciarini M; Tucker SJ; Imbrici P; Shehab S; Pessia M; Brancorsini S; D'Adamo MC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205849
[TBL] [Abstract][Full Text] [Related]
5. Diverse functions of the inward-rectifying potassium channel Kir5.1 and its relationship with human diseases.
Zhang C; Guo J
Front Physiol; 2023; 14():1127893. PubMed ID: 36923292
[TBL] [Abstract][Full Text] [Related]
6. Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer.
Zhang J; Zhao A; Jia X; Li X; Liang Y; Liu Y; Xie X; Qu X; Wang Q; Zhang Y; Gao R; Yu Y; Yang A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142613
[TBL] [Abstract][Full Text] [Related]
7. Kir5.1 channels: potential role in epilepsy and seizure disorders.
Staruschenko A; Hodges MR; Palygin O
Am J Physiol Cell Physiol; 2022 Sep; 323(3):C706-C717. PubMed ID: 35848616
[TBL] [Abstract][Full Text] [Related]
8. Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease.
Kompatscher A; de Baaij JHF; Aboudehen K; Hoefnagels APWM; Igarashi P; Bindels RJM; Veenstra GJC; Hoenderop JGJ
Kidney Int; 2017 Nov; 92(5):1145-1156. PubMed ID: 28577853
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutation of Kcnj16 identifies Kir5.1-containing channels as key regulators of acute and chronic pH homeostasis.
Puissant MM; Muere C; Levchenko V; Manis AD; Martino P; Forster HV; Palygin O; Staruschenko A; Hodges MR
FASEB J; 2019 Apr; 33(4):5067-5075. PubMed ID: 30605394
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the renin-angiotensin-aldosterone system and renal Kir5.1 channels.
Manis AD; Palygin O; Khedr S; Levchenko V; Hodges MR; Staruschenko A
Clin Sci (Lond); 2019 Dec; 133(24):2449-2461. PubMed ID: 31799617
[TBL] [Abstract][Full Text] [Related]
11. Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection.
Feng F; Wang H; Hou S; Fu H
Nucl Med Biol; 2012 Nov; 39(8):1261-5. PubMed ID: 22898315
[TBL] [Abstract][Full Text] [Related]
12. Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.
Davies TF; Latif R
Expert Opin Ther Targets; 2015 Jun; 19(6):835-47. PubMed ID: 25768836
[TBL] [Abstract][Full Text] [Related]
13. Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSAME/EAST syndrome.
Paulais M; Bloch-Faure M; Picard N; Jacques T; Ramakrishnan SK; Keck M; Sohet F; Eladari D; Houillier P; Lourdel S; Teulon J; Tucker SJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10361-6. PubMed ID: 21633011
[TBL] [Abstract][Full Text] [Related]
14. Targeting the TSH receptor in thyroid cancer.
Rowe CW; Paul JW; Gedye C; Tolosa JM; Bendinelli C; McGrath S; Smith R
Endocr Relat Cancer; 2017 Jun; 24(6):R191-R202. PubMed ID: 28351942
[TBL] [Abstract][Full Text] [Related]
15. Biallelic loss-of-function variants in KCNJ16 presenting with hypokalemic metabolic acidosis.
Webb BD; Hotchkiss H; Prasun P; Gelb BD; Satlin L
Eur J Hum Genet; 2021 Oct; 29(10):1566-1569. PubMed ID: 33840812
[TBL] [Abstract][Full Text] [Related]
16. Expression of sodium/iodide transporters and thyroid stimulating hormone receptors in thyroid cancer patients and its correlation with iodine nutrition status and pathology.
Li J; Dong JN; Zhao Z; Lv Q; Yun B; Liu JQ; Cai XY
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4573-4580. PubMed ID: 30058701
[TBL] [Abstract][Full Text] [Related]
17. Inwardly rectifying potassium channel 5.1: Structure, function, and possible roles in diseases.
Zhang J; Han J; Li L; Zhang Q; Feng Y; Jiang Y; Deng F; Zhang Y; Wu Q; Chen B; Hu J
Genes Dis; 2021 May; 8(3):272-278. PubMed ID: 33997174
[TBL] [Abstract][Full Text] [Related]
18. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells.
Ma R; Latif R; Davies TF
Thyroid; 2013 Apr; 23(4):385-91. PubMed ID: 23360087
[TBL] [Abstract][Full Text] [Related]
19. Molecular insights into the possible role of Kir4.1 and Kir5.1 in thyroid hormone biosynthesis.
Ramos HE; da Silva MR; Carré A; Silva JC; Paninka RM; Oliveira TL; Tron E; Castanet M; Polak M
Horm Res Paediatr; 2015; 83(2):141-7. PubMed ID: 25612510
[TBL] [Abstract][Full Text] [Related]
20. Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity.
D'Adamo MC; Shang L; Imbrici P; Brown SD; Pessia M; Tucker SJ
J Biol Chem; 2011 Jan; 286(1):192-8. PubMed ID: 21047793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
